Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Virchows Archiv : an International Journal of Pathology|December 6, 2019
IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implicationsMassimo Granai, Teresa Amato, Arianna Di Napoli, et al.
Virchows Archiv : an International Journal of Pathology|March 20, 2020
Correction to: IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implicationsMassimo Granai, Teresa Amato, Arianna Di Napoli, et al.
Infectious Agents and Cancer|June 13, 2020
Correction to: Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency programMassimo Granai, Lucia Mundo, Ayse U Akarca, et al.
Infectious Agents and Cancer|May 12, 2020
Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency programMassimo Granai, Lucia Mundo, Ayse U Akarca, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 1, 2020
Correction: Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomasLucia Mundo, Leonardo Del Porro, Massimo Granai, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 3, 2020
Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomasLucia Mundo, Leonardo Del Porro, Massimo Granai, et al.
Histopathology|May 5, 2021
Burkitt lymphoma with a granulomatous reaction: an M1/Th1-polarised microenvironment is associated with controlled growth and spontaneous regressionMassimo Granai, Stefano Lazzi, Virginia Mancini, et al.
Blood Cancer Journal|November 22, 2019
Molecular switch from MYC to MYCN expression in MYC protein negative Burkitt lymphoma casesLucia Mundo, Maria Raffaella Ambrosio, Francesco Raimondi, et al.
Frontiers in Oncology|May 24, 2021
Exome sequencing in BRCA1-2 candidate familias: the contribution of other cancer susceptibility genesGabriella Doddato, Floriana Valentino, Annarita Giliberti, et al.
Frontiers in Oncology|September 6, 2021
Corrigendum: Exome Sequencing in BRCA1-2 Candidate Familias: The Contribution of Other Cancer Susceptibility GenesGabriella Doddato, Floriana Valentino, Annarita Giliberti, et al.
Pageof 3